Salve for the Wound Care Market
This article was originally published in Start Up
Wound care, once known as an investment graveyard, is changing. An advanced wound care market that once focused high-end technology on the small and difficult market of burns has now recognized an opportunity in chronic wounds, an enormous and growing market driven by the demographics of aging, and that segment has recently witnessed a dramatic success story. In 2004, the most successful medical device IPO was that of wound care company Kinetic Concepts.
You may also be interested in...
KeraCure has developed a cell-based product for chronic wounds called KeraPac. The product contains living keratinocytes and will have an extended shelf life to allow wound care centers to store the product in its clinics, where it will be available for immediate use.
There are four pillars of chronic wound care, and few products address all of them satisfactorily. The four factors encouraging wound healing include debridement, bacterial management, increased blood circulation, and the stimulation of healthy cells. Celleration believes it has all four requirements covered with its MIST Therapy System ultrasound device for wound healing.
Deion Sanders invests in RedCon1, helps with product design; Mayweather needs investors in fitness projects; ‘Excellent Adventure’ and limited flavor in G Fuel box; and GAT Sport collaborates with Jeremy Buendia.